EGFR and cancer: Martinez-Alarcon et al. [31] reported that rTBL-1 recognizes β1-6-branched N-glycans present in receptors, such as EGFR, overexpressed in cancer cells; therefore, we evaluated if there was an interaction between rTBL-1 and EGFR as part of the apoptotic mechanism of action.